Literature DB >> 28875410

High-Risk Geographic Mobility Patterns among Young Urban and Suburban Persons who Inject Drugs and their Injection Network Members.

Basmattee Boodram1, Anna L Hotton2, Louis Shekhtman3,4, Alexander Gutfraind3, Harel Dahari3.   

Abstract

Young people in the USA who inject drugs, particularly those at a risk of residence instability, experience the highest incidence of hepatitis C (HCV) infections. This study examined associations between geographic mobility patterns and sociodemographic, behavioral, and social network characteristics of 164 young (ages 18-30) persons who inject drugs (PWID). We identified a potential bridge sub-population who reported residence in both urban and suburban areas in the past year (crossover transients) and higher-risk behaviors (receptive syringe sharing, multiple sex partners) compared to their residentially localized counterparts. Because they link suburban and urban networks, crossover transients may facilitate transmission of HIV and HCV between higher and lower prevalence areas. Interventions should address risk associated with residential instability, particularly among PWID who travel between urban and suburban areas.

Entities:  

Keywords:  Hepatitis C; Injection drug use; Mobility; Persons who inject drugs; Suburban; Transience

Mesh:

Year:  2018        PMID: 28875410      PMCID: PMC5862693          DOI: 10.1007/s11524-017-0185-7

Source DB:  PubMed          Journal:  J Urban Health        ISSN: 1099-3460            Impact factor:   3.671


  52 in total

1.  Drug use and HIV risk practices of secondary and primary needle exchange users.

Authors:  Dezheng Huo; Susan L Bailey; Ronald C Hershow; Lawrence Ouellet
Journal:  AIDS Educ Prev       Date:  2005-04

2.  Non-injection and injection drug use and STI/HIV risk in the United States: the degree to which sexual risk behaviors versus sex with an STI-infected partner account for infection transmission among drug users.

Authors:  Maria R Khan; Amanda Berger; Jordana Hemberg; Allison O'Neill; Typhanye Penniman Dyer; Kristina Smyrk
Journal:  AIDS Behav       Date:  2013-03

3.  Prevalence of psychiatric disorders among young injection drug users.

Authors:  Mary E Mackesy-Amiti; Geri R Donenberg; Lawrence J Ouellet
Journal:  Drug Alcohol Depend       Date:  2012-01-09       Impact factor: 4.492

4.  Hepatitis C virus infection among adolescents and young adults:Massachusetts, 2002-2009.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2011-05-06       Impact factor: 17.586

5.  Individual and network factors associated with prevalent hepatitis C infection among rural Appalachian injection drug users.

Authors:  Jennifer R Havens; Michelle R Lofwall; Simon D W Frost; Carrie B Oser; Carl G Leukefeld; Richard A Crosby
Journal:  Am J Public Health       Date:  2012-11-15       Impact factor: 9.308

6.  Limited uptake of hepatitis C treatment among injection drug users.

Authors:  Shruti H Mehta; Becky L Genberg; Jacquie Astemborski; Ravi Kavasery; Gregory D Kirk; David Vlahov; Steffanie A Strathdee; David L Thomas
Journal:  J Community Health       Date:  2008-06

7.  Acute hepatitis C virus infection in young adult injection drug users: a prospective study of incident infection, resolution, and reinfection.

Authors:  Kimberly Page; Judith A Hahn; Jennifer Evans; Stephen Shiboski; Paula Lum; Eric Delwart; Leslie Tobler; William Andrews; Lia Avanesyan; Stewart Cooper; Michael P Busch
Journal:  J Infect Dis       Date:  2009-10-15       Impact factor: 5.226

8.  Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis.

Authors:  Adriaan J van der Meer; Bart J Veldt; Jordan J Feld; Heiner Wedemeyer; Jean-François Dufour; Frank Lammert; Andres Duarte-Rojo; E Jenny Heathcote; Michael P Manns; Lorenz Kuske; Stefan Zeuzem; W Peter Hofmann; Robert J de Knegt; Bettina E Hansen; Harry L A Janssen
Journal:  JAMA       Date:  2012-12-26       Impact factor: 56.272

9.  HIV infection and HIV-associated behaviors among persons who inject drugs--20 cities, United States, 2012.

Authors:  Michael W Spiller; Dita Broz; Cyprian Wejnert; Lina Nerlander; Gabriela Paz-Bailey
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-03-20       Impact factor: 17.586

10.  Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection.

Authors:  Mark S Sulkowski; David F Gardiner; Maribel Rodriguez-Torres; K Rajender Reddy; Tarek Hassanein; Ira Jacobson; Eric Lawitz; Anna S Lok; Federico Hinestrosa; Paul J Thuluvath; Howard Schwartz; David R Nelson; Gregory T Everson; Timothy Eley; Megan Wind-Rotolo; Shu-Pang Huang; Min Gao; Dennis Hernandez; Fiona McPhee; Diane Sherman; Robert Hindes; William Symonds; Claudio Pasquinelli; Dennis M Grasela
Journal:  N Engl J Med       Date:  2014-01-16       Impact factor: 91.245

View more
  12 in total

1.  Modeling indicates efficient vaccine-based interventions for the elimination of hepatitis C virus among persons who inject drugs in metropolitan Chicago.

Authors:  Desarae Echevarria; Alexander Gutfraind; Basmattee Boodram; Jennifer Layden; Jonathan Ozik; Kimberly Page; Scott J Cotler; Marian Major; Harel Dahari
Journal:  Vaccine       Date:  2019-04-05       Impact factor: 3.641

2.  Feasibility of ecological momentary assessment to study mood and risk behavior among young people who inject drugs.

Authors:  Mary E Mackesy-Amiti; Basmattee Boodram
Journal:  Drug Alcohol Depend       Date:  2018-04-16       Impact factor: 4.492

Review 3.  Social Networks of Substance-Using Populations: Key Issues and Promising New Approaches for HIV.

Authors:  Brooke S West
Journal:  Curr HIV/AIDS Rep       Date:  2019-02       Impact factor: 5.071

4.  How to eliminate HCV in people who inject drugs in the USA.

Authors:  Harel Dahari; Basmattee Boodram
Journal:  Lancet Infect Dis       Date:  2017-11-15       Impact factor: 25.071

5.  Association of Injection Practices and Overdose With Drug Use Typologies: A Latent Class Analysis Among People Who Inject Drugs in Baltimore, 2017.

Authors:  Rachel E Gicquelais; Becky L Genberg; Jacquie Astemborski; David D Celentano; Gregory D Kirk; Shruti H Mehta
Journal:  AIDS Educ Prev       Date:  2019-08

6.  Gaps in HCV Knowledge and Risk Behaviors among Young Suburban People Who Inject Drugs.

Authors:  John J Jost; Barbara Tempalski; Tatiana Vera; Matthew J Akiyama; Aprille P Mangalonzo; Alain H Litwin
Journal:  Int J Environ Res Public Health       Date:  2019-06-02       Impact factor: 3.390

7.  Quantifying people's experience during flood events with implications for hazard risk communication.

Authors:  Nataliya Tkachenko; Rob Procter; Stephen Jarvis
Journal:  PLoS One       Date:  2021-01-07       Impact factor: 3.240

8.  Drug use-related stigma, safer injection norms, and hepatitis C infection among a network-based sample of young people who inject drugs.

Authors:  Leslie D Williams; Mary Ellen Mackesy-Amiti; Carl Latkin; Basmattee Boodram
Journal:  Drug Alcohol Depend       Date:  2021-02-17       Impact factor: 4.492

9.  HCV incidence is associated with injecting partner age and HCV serostatus mixing in young adults who inject drugs in San Francisco.

Authors:  Kimberly Page; Jennifer L Evans; Judith A Hahn; Peter Vickerman; Stephen Shiboski; Meghan D Morris
Journal:  PLoS One       Date:  2019-12-10       Impact factor: 3.240

10.  Modeling hepatitis C micro-elimination among people who inject drugs with direct-acting antivirals in metropolitan Chicago.

Authors:  Eric Tatara; Alexander Gutfraind; Nicholson T Collier; Desarae Echevarria; Scott J Cotler; Marian E Major; Jonathan Ozik; Harel Dahari; Basmattee Boodram
Journal:  PLoS One       Date:  2022-03-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.